Time trend in transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry

Jiménez‐Quevedo, Pilar; Muñoz-García, Antonio J.; Trillo-Nouche, Ramiro; Valle, Raquel del; Salido, Luisa; Gutiérrez, Enrique; Pan, Manuel; Sánchez-Gila, Joaquín; Blanco, Bruno García del; Moreno, Raúl; Mata, Roberto Blanco; Oteo, Juan Francisco; Amat‐Santos, Ignacio J.; Regueiro, Ander; Ten, Francisco; Nogales, Juan; Fernández-Nofrerías, Eduard; Andraka, Leire; Ferrer, María Cruz; Pinar, Eduardo; Romaguera, Rafael; Ramón, Carlos Cuellas; Alfonso, Fernándo; García‐Blas, Sergio; Piñero, Antonio; Julia, Ignasi; Méndez, Rocío Díaz; Bordes, Pascual; Meseguer, Juan; Nombela‐Franco, Luis; registry, Spanish Tavi

doi:10.24875/recice.m20000104

Cited by 2 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Approximately 5% of TAVI procedures are being currently performed to treat degenerated aortic biological valves 15 . These procedures are associated with higher risk of some clinical complications (e.g., coronary occlusion) and worse hemodynamic behavior, mainly because of higher trans‐valvular gradients after the procedure, especially with small bioprosthesis 2‐4,16 .…”

Section: Discussionmentioning

confidence: 99%

Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra‐annular device. The Spanish Allegra valve‐in‐valve (SAVIV) registry

Moreno

Baz

Moreu

et al. 2021

Cathet Cardio Intervent

Self Cite

View full text Add to dashboard Cite

Objectives The objective was to evaluate the results of valve‐in‐valve procedures performed with the Allegra device. Background Transcatheter aortic valve implantation to treat degenerated biological aortic valves (valve‐in‐valve) is an established procedure in most catheterization laboratories, but the results are poorer than procedures done in native aortic stenosis. The Allegra device (Biosensors, Morges, Switzerland) has an excellent design to treat these patients. Methods All patients with severely degenerated biological aortic valve treated with the Allegra device in centers from Spain until December 2020 were included (n = 29). Hemodynamic results and 30‐day clinical outcomes were evaluated. The predominant hemodynamic failure was stenosis in 15, regurgitation in 11, and a combination of both in 3 cases. Time from aortic valve replacement to valve‐in‐valve procedure was 8.4 ± 3.9 years (range 3.3–22.1). Results After the procedure, maximum and mean trans‐valvular gradients were 17.4 ± 12.3 and 8.4 ± 6.1 mmHg, respectively. Device success was obtained in 28 patients (96.6%). In one patient with a degenerated 19 mm prosthetic valve, mean gradient after the procedure was 22 mmHg. No patients had a para‐valvular leak grade >1. There were no deaths during the hospitalization or at 30 days and one patient suffered a stroke. Conclusions The Allegra trans‐catheter aortic valve offers optimal hemodynamic results in patients with severely degenerated biological aortic valve.

show abstract

Section: Discussionmentioning

confidence: 99%

Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra‐annular device. The Spanish Allegra valve‐in‐valve (SAVIV) registry

Moreno

Baz

Moreu

et al. 2021

Cathet Cardio Intervent

Self Cite

View full text Add to dashboard Cite

show abstract

“…However, the presence of pre-existing LBBB in patients undergoing TAVR has not been considered a risk factor for adverse long-term outcomes in these patients, and in the absence of electrocardiographic changes after valve implantation, it might have been perceived by physicians as a benign bystander. 6 As we move toward TAVR in lower-risk populations with longer lifespans, 7 it is important to address all factors that can influence prognosis.…”

mentioning

confidence: 99%

Left Bundle Branch Block in Aortic Stenosis

Tamargo,

Gutiérrez-Ibañes

2024

JACC: Asia

View full text Add to dashboard Cite

Time trend in transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry

Cited by 2 publications

References 17 publications

Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra‐annular device. The Spanish Allegra valve‐in‐valve (SAVIV) registry

Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra‐annular device. The Spanish Allegra valve‐in‐valve (SAVIV) registry

Left Bundle Branch Block in Aortic Stenosis

Contact Info

Product

Resources

About